[Group B streptococcal early-onset neonatal sepsis in the area of Barcelona (2004-2010). Analysis of missed opportunities for prevention]

Enferm Infecc Microbiol Clin. 2015 Aug-Sep;33(7):446-50. doi: 10.1016/j.eimc.2014.10.015. Epub 2014 Dec 23.
[Article in Spanish]

Abstract

Objectives: To study the evolution of the incidence of early-onset neonatal sepsis (EOS) by Streptococcus agalactiae in the area of Barcelona and to analyze failure of compliance with the prevention protocol.

Methods: A retrospective review was carried out on EOS cases in 8 Health-Care Centers in the Barcelona area between 2004 and 2010.

Results: Forty-nine newborns from 48 mothers were diagnosed with EOS. The incidence was 0.29‰ living newborns (0.18-0.47‰), with no significant differences in the fluctuations along the 7 years. The mortality rate was 8.16%. In 68.5% cases the maternal colonization studies were negative, and in 21% these studies were not performed. No risk factors were detected in 58.3% of pregnant women, and 22.9% of births were premature. In 58% of cases intra-partum antibiotic prophylaxis was not administered because it was not indicated, and in 42% due to failure to follow the protocol (3 strains were resistant to erythromycin). Resistance to clindamycin was 33.3%. The Streptococcus agalactiae serotypes more frequently isolated were iii, v, and ia.

Conclusions: No significant changes were detected in the incidence of Streptococcus agalactiae EOS in the 7 years of the study. The increased sensitivity of screening methods with the use of molecular techniques, the performance of susceptibility testing of strains isolated from pregnant women, and the improvement of communication between Health-Care Centers, can contribute to a better implementation of the protocol, as well as to reduce the incidence of EOS.

Keywords: Early-onset neonatal sepsis; Intra-partum chemoprophylaxis; Prevención; Prevention; Profilaxis intraparto; Sepsis neonatal precoz; Streptococcus agalactiae.

Publication types

  • Multicenter Study

MeSH terms

  • Age of Onset
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis / statistics & numerical data
  • Cesarean Section / statistics & numerical data
  • Delayed Diagnosis
  • Delivery, Obstetric
  • False Negative Reactions
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Neonatal Sepsis / drug therapy
  • Neonatal Sepsis / epidemiology*
  • Neonatal Sepsis / microbiology
  • Neonatal Sepsis / prevention & control
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pregnancy Complications, Infectious / epidemiology
  • Retrospective Studies
  • Risk Factors
  • Spain / epidemiology
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / epidemiology*
  • Streptococcal Infections / microbiology
  • Streptococcal Infections / prevention & control
  • Streptococcus agalactiae / isolation & purification*
  • Urban Population

Substances

  • Anti-Bacterial Agents